Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 19, 2026.

The Harris hip score: Do ceiling effects limit its usefulness in orthopedics?

Kim E Wamper, Inger N Sierevelt, Rudolf W Poolman and 2 more

Acta Orthopaedica · 2010 · Systematic review

doi:10.3109/17453674.2010.537808

Abstract

Background and purpose. The Harris hip score (HHS), a disease-specific health status scale that is frequently used to measure the outcome of total hip arthroplasty, has never been validated properly. A questionnaire is suitable only when all 5 psychometric properties are of sufficient quality. We questioned the usefulness of the HHS by investigating its content validity.

Methods. We performed a systematic review based on a literature search in PubMed, Embase, and the Cochrane Library for descriptive studies published in 2007. 54 studies (59 patient groups) met our criteria and were included in the data analysis. To determine the content validity, we calculated the ceiling effect (percentage) for each separate study and we pooled data to measure the weighted mean. A subanalysis of indications for THA was performed to differentiate the populations for which the HHS would be suitable and for which it would not. A ceiling effect of 15% or less was considered to be acceptable.

Results. Over half the studies (31/59) revealed unacceptable ceiling effects. Pooled data across the studies included (n = 6,667 patients) suggested ceiling effects of 20% (95%CI: 18–22). Ceiling effects were greater (32%, 95%CI:12–52) in those patients undergoing hip resurfacing arthroplasty.

Interpretation. Although the Harris hip score is widely used in arthroplasty research on outcomes, ceiling effects are common and these severely limit its validity in this field of research.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 19, 2026. Paragraph numbers are ours, so an answer can point at one.

In evidence-based medicine, the use of clinically important patient outcomes in clinical research is paramount. Quality of life and function are usually measures that are important for patients and healthcare providers. The Harris hip score (HHS) is one such measure that has frequently been used to measure outcome after total hip arthroplasty.

developed this score with a rating scale of 100 points and with domains of pain, function, activity, deformity, and motion. It was designed for use in young men with often long-standing severe secondary osteoarthritis after a fracture of the acetabulum that was operated on with a Smith-Petersen vitallium mold arthroplasty. Although not originally designed for hip arthroplasty (THA) patients, it is widely used for this population. Since its introduction, several authors have reported the score to be a valid outcome measure for THA based on good construct validity alone. While construct validity is important, it is not the sole factor in evaluating the overall validity of an outcome questionnaire. Reliability, internal consistency, content validity, and responsiveness are also important. A questionnaire is suitable only when all 5 psychometric properties are of sufficient quality.

Content validity assesses the extent to which a metric measures all aspects of a certain phenomenon. The amount of ceiling and floor effects present determine the quality of the content validity. A floor effect occurs when several of the patients score the lowest possible score, whereas a ceiling effect occurs when several of the patients score the highest possible score.

Given the persistent use of the HHS in clinical research, we systemically reviewed clinical trials of primary hip arthroplasty using the HHS as an outcome measure. We hypothesized that ceiling effects are common, thereby limiting the validity of the HHS in arthroplasty outcome research.

Methods

Our systematic review conformed to the PRISMA guidelines for reporting of meta-analyses and systematic reviews.

Information sources and search

We performed a systematic review of the literature by performing a computerized literature search in PubMed, Embase, and the Cochrane Library for studies published in 2007, searching for “hip” and “arthroplasty” both as free text and as MESH terms.

Eligibility criteria

We included all descriptive trials, both prospective and retrospective, reporting on the outcome of primary total hip arthroplasty. Our inclusion criteria for further analysis were: articles published in English, patients undergoing primary total hip arthroplasty, and a range (standard deviation) of the HHS score reported in the article.

Study selection

2 of the authors (DH and KW) independently selected titles and abstracts for possible inclusion. Full-text manuscripts were retrieved for any abstracts that appeared potentially eligible. The final decision to include a paper was based on a consensus between the 2 reviewers.

The data collection process

Data extraction was performed independently by the same 2 authors (KW and DH), after which the data were compared and a consensus obtained.

Calculation of ceiling effects

Harris hip scores were reported as averages with SD or range. If no SD was given in the study, it was calculated from the range to estimate the percentage ceiling effect. A ceiling effect means that several patients score the highest possible score, thus they “reach the ceiling”. A ceiling effect is caused when the test items are not challenging enough for a group of individuals because the test has a limited number of difficult items or even an inappropriate item selection. It will lead to a shortcoming in the discriminative ability of the test to detect clinically relevant changes; a person may continue to improve, but the test does not capture that improvement. A floor or ceiling effect of 15% is considered the maximum acceptable.

Analysis

As described by, it is possible to estimate the SD from a study when the mean and range and the size of the population is known. This method is widely used and accepted. We used it to estimate the SD for those studies where only the range and size (n) were given. In this data calculation, we assumed a normal distribution in the patient populations. This allowed us to estimate the percentage of ceiling effect present. This was calculated for each separate study, and data were also pooled to calculate a weighted overall percentage for all patients.

We performed a subgroup analysis based on the indication for THA to assess whether the HHS would be suitable for any subgroup. Also, a subanalysis for the influence of age and length of follow-up on the content validity was performed. Finally, we conducted a subgroup analysis evaluating ceiling effect in patients who underwent hip resurfacing arthroplasties.

We report a descriptive analysis of the ceiling effects, as percentage with 95% confidence interval (CI). For analysis, we used the HHS score from the latest follow-up reported. A linear logistic regression was performed to search for factors influencing the percentage ceiling effect (indication, retrospective or prospective trial, average age, length of follow-up period, or type of procedure (hip resurfacing, minimally invasive techniques, or normal THA). Statistical analyses were performed using SPSS software version 15.0.

Literature search

Of 764 potential studies, 54 studies—of which 59 groups could be reviewed (5 trials were comparative, describing 2 populations; altogether, 6,667 patients)—were suitable for inclusion. Figure shows the reasons for exclusion of certain studies. 45 studies reported primary THA for several indications, 13 of which focused on specific patient populations (4 osteonecrosis, 9 dysplasia). Hip resurfacing was reported in 4 studies. Details of each study included are given in the Table.

Ceiling effects

31/59 patient groups showed a ceiling effect greater than 15%. Pooling across the 59 patient groups showed a ceiling effect of 20% (CI: 18–22).

When studies needing a calculation of SD were excluded and only the 14 studies in which an SD was given were included, we found an average ceiling effect of 15.8% (4–30); 7 of the 14 studies had a ceiling effect of more than 15%.

In the studies evaluating total hip arthroplasty in patients with avascular necrosis of the femoral head, the ceiling effect averaged 16% (CI: 8–24). Similarly, in patients with total hip arthroplasty for osteoarthritis secondary to dysplasia, the ceiling effect averaged 24% (CI: 18–31). In patients treated with a hip resurfacing, the mean ceiling effect was 32% (CI: 12–52).

Indication, study design, patient age, length of follow-up, and type of procedure had no statistically significant influence on the magnitude of the ceiling effect (p-values all > 0.05).

Key findings

Our review shows that the Harris hip score has frequent ceiling effects in trials evaluating outcomes of primary hip arthroplasty, which indicates that it has limited application in exploration of treatment differences using newer techniques.

Strengths and limitations

Our meta-analysis has several strengths. We used a comprehensive systematic approach to identify relevant papers, we assessed the reliability of our assessments, and included a sufficient number of trials to be able to reach a conclusion. Finally, our systematic review followed the international PRISMA guidelines for reporting.

Our review does have some limitations. We calculated ceiling effect based on the assumption that scores in every population had a normal distribution. It is possible that normality was not met due to insufficient sample size, or merely because of the existence of the ceiling effect we were trying to investigate. However, in half of studies in which the SD was given rather than calculated by us, a ceiling effect was found. We determined only the ceiling effects and not floor effects because we believed that ceiling effects are the main limitations of the Harris hip score. None of the studies that investigated the reliability included the floor score in the range of distribution, while most included the ceiling value of 100.

Previous literature

In 1969, when the HHS was developed, it probably had excellent content validity due to the nature of the patient population and type of implant at that time. However, indications for joint replacement have expanded over time and improvements in implant designs and techniques have led to improved outcomes. The ability of a functional outcome measure to distinguish clinically relevant improvements in outcomes with changes in prosthetic design is important. Ceiling effects in an instrument can hide these differences when patients already score the maximum possible score and cannot improve on that score. For example, a 75-year-old patient just able to walk 2 hours at a normal pace would have the same score as a 45-year-old patient who has returned to running marathons.

Implications for future research

There are plenty of alternative scoring systems, including the WOMAC score, the Oxford 12-item questionnaire, and the HOOS. evaluated the WOMAC score and the Oxford 12-item questionnaire for validity. The Oxford hip score did well in their study on all validity items. evaluated the content validity of the Dutch version of the hip disability and osteoarthritis outcome score (HOOS) and reported no ceiling effect and good validity.

Besides having a problematic ceiling effect, HHS includes a physician's physical examination component. Previous studies have shown that physical examination has a high intraobserver variablility. Consequently, investigators have commonly used a modified Harris hip score without the physical examination part. Thus, the modified HHS suffers the drawbacks of ceiling effects as well as the problems of a non-validated modification of the original HHS score.

Conclusion

Based on our systematic review and meta-analysis, we conclude that the Harris hip score commonly shows ceiling effects, which limit its usefulness in trials evaluating the efficacy of primary total hip arthroplasty.

References 16

  1. 1.

    de Groot IB, Reijman M, Terwee CB, Bierma-Zeinstra S, Favejee MM, Roos E, Verhaar JA. Validation of the Dutch version of the Hip disability and Osteoarthritis Outcome Score. Osteoarthritis Cartilage. 2009;17((1)):132.

    Not in our library10.1016/j.joca.2008.05.014

  2. 2.

    Gosens T, Hoefnagels NH, de Vet RC, Dhert WJ, van Langelaan EJ, Bulstra SK, Geesink RG. The “Oxford Heup Score”: the translation and validation of a questionnaire into Dutch to evaluate the results of total hip arthroplasty. Acta Orthop. 2005;76((2)):204-11.

    Not in our library10.1080/00016470510030580

  3. 3.

    Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg (Am). 1969;51((4)):737-55.

    Not in our library

  4. 4.

    Haverkamp D, Sierevelt IN, Bekerom van den MP, Poolman RW, Dijk van CN, Marti RK. The validity of patient satisfaction as single question in outcome measurement of total hip arthroplasty. J Long Term Eff Med Implants. 2008;18((2)):145-50.

    Not in our library10.1615/jlongtermeffmedimplants.v18.i2.30

  5. 5.

    Kirmit L, Karatosun V, Unver B, Bakirhan S, Sen A, Gocen Z. The reliability of hip scoring systems for total hip arthroplasty candidates: assessment by physical therapists. Clin Rehabil. 2005;19((6)):659-61.

    Not in our library10.1191/0269215505cr869oa

  6. 6.

    McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res. 1995;4((4)):293-307.

    Not in our library10.1007/bf01593882

  7. 7.

    Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62((10)):1006-12.

    Not in our library10.1016/j.jclinepi.2009.06.005

  8. 8.

    Ostendorf M, van Stel HF, Buskens E, Schrijvers AJ, Marting LN, Verbout AJ, Dhert WJ. Patient-reported outcome in total hip replacement. A comparison of five instruments of health status. J Bone Joint Surg (Br). 2004;86((6)):801-8.

    Not in our library10.1302/0301-620x.86b6.14950

  9. 9.

    Poolman RW, Swiontkowski MF, Fairbank JC, Schemitsch EH, Sprague S, de Vet HC. Outcome instruments: rationale for their use. J Bone Joint Surg (Am) (Suppl 3). 2009;91:41-9.

    Not in our library10.2106/jbjs.h.01551

  10. 10.

    Ragab AA. Validity of self-assessment outcome questionnaires: patient-physician discrepancy in outcome interpretation. Biomed Sci Instrum. 2003;39:579-84.

    Not in our library

  11. 11.

    Roorda LD, Jones CA, Waltz M, Lankhorst GJ, Bouter LM, van der Eijken JW, Willems WJ, Heyligers IC, Voaklander DC, Kelly KD, Suarez-Almazor ME. Satisfactory cross cultural equivalence of the Dutch WOMAC in patients with hip osteoarthritis waiting for arthroplasty. Ann Rheum Dis. 2004;63((1)):36-42.

    Not in our library10.1136/ard.2002.001784

  12. 12.

    Shi HY, Mau LW, Chang JK, Wang JW, Chiu HC. Responsiveness of the Harris Hip Score and the SF-36: five years after total hip arthroplasty. Qual Life Res. 2009;18((8)):1053-60.

    Not in our library10.1007/s11136-009-9512-0

  13. 13.

    Soderman P, Malchau H. Is the Harris Hip Score system useful to study the outcome of total hip replacement? Clin Orthop. 2001;((384)):189-97.

    Not in our library10.1097/00003086-200103000-00022

  14. 14.

    Terwee CB, Bot SD, De Boer MR, van der Windt DA, Knol DL, Dekker J, Bouter LM, de Vet HC. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60((1)):34-42.

    Not in our library10.1016/j.jclinepi.2006.03.012

  15. 15.

    Walter SD, Yao X. Effect sizes can be calculated for studies reporting ranges for outcome variables in systematic reviews. J Clin Epidemiol. 2007;60((8)):849-52.

    Not in our library10.1016/j.jclinepi.2006.11.003

  16. 16.

    Wright JG, Young NL. A comparison of different indices of responsiveness. J Clin Epidemiol. 1997;50((3)):239-46.

    Not in our library10.1016/s0895-4356(96)00373-3

Cited by papers we hold 3

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.